Genomic risk of hepatitis C-related hepatocellular carcinoma

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
The impact of hepatitis E in the liver transplant setting
Volume 65, Issue 1, Pages S82-S94 (October 2016)
Inflammasomes in liver diseases
Volume 61, Issue 4, Pages (October 2014)
Volume 67, Issue 2, Pages (August 2017)
Volume 50, Issue 4, Pages (April 2009)
Hepatic CD141+IFNλ+ DC subset: One against all?
Volume 68, Issue 5, Pages (May 2018)
Julien Bissonnette, Dominique Valla, Pierre-Emmanuel Rautou 
Volume 61, Issue 6, Pages (December 2014)
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
The impact of hepatitis E in the liver transplant setting
Reactive oxygen species in the normal and acutely injured liver
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Volume 65, Issue 1, Pages S82-S94 (October 2016)
Immigration and viral hepatitis
Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis  Astrid Marot, Jean Henrion, Jean-François.
Hepatitis B and C virus-related carcinogenesis
Living donor liver transplantation: is the hype over?
David G. Bowen, Christopher M. Walker  Journal of Hepatology 
Volume 69, Issue 2, Pages (August 2018)
Volume 44, Pages S19-S24 (January 2006)
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection  Anaïs Vallet-Pichard,
The place of downstaging for hepatocellular carcinoma
Volume 58, Issue 3, Pages (March 2013)
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
European Association for the Study of the Liver  Journal of Hepatology 
Volume 68, Issue 1, Pages (January 2018)
Hepatitis C core protein – The “core” of immune deception?
Targeting gut flora to prevent progression of hepatocellular carcinoma
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
Volume 70, Issue 1, Pages (January 2019)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Trends in the management and burden of alcoholic liver disease
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Why men are at higher risk for hepatocellular carcinoma?
Volume 62, Issue 3, Pages (March 2015)
Autophagy in the liver Journal of Hepatology
Volume 66, Issue 2, Pages (February 2017)
EASL Clinical Practice Guidelines: Wilson’s disease
Pierre Nahon, Jessica Zucman-Rossi  Journal of Hepatology 
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
Giovanni Addolorato, Antonio Mirijello, Pablo Barrio, Antoni Gual 
Hepatitis B and C virus-related carcinogenesis
Volume 50, Issue 4, Pages (April 2009)
Non-invasive diagnosis and biomarkers in alcohol-related liver disease
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Volume 61, Issue 1, Pages S79-S90 (November 2014)
Chetana Lim, Chady Salloum, Daniel Azoulay
Volume 50, Issue 3, Pages (March 2009)
Immigration and viral hepatitis
Evolution of liver transplantation for hepatocellular carcinoma
Kornelius Schulze, Jean-Charles Nault, Augusto Villanueva 
Role of desmoplasia in cholangiocarcinoma and hepatocellular carcinoma
Volume 63, Issue 1, Pages (July 2015)
Volume 51, Issue 2, Pages (August 2009)
Hepatitis C infection: A multi-faceted systemic disease with clinical, patient reported and economic consequences  Zobair M. Younossi, Aybike Birerdinc,
Integrating sorafenib into an algorithm for the management of post-transplant hepatocellular carcinoma recurrence  Christian Toso, Gilles Mentha, Pietro.
Pathogenesis of cholestatic hepatitis C
Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: Insights from next generation DNA sequencing  Roongruedee Chaiteerakij,
Chimeric mouse model of hepatitis B virus infection
Genetics of hepatocellular carcinoma: The next generation
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Outcomes in liver transplantation: Does sex matter?
Reversion of disease manifestations after HCV eradication
Presentation transcript:

Genomic risk of hepatitis C-related hepatocellular carcinoma Yujin Hoshida, Bryan C. Fuchs, Kenneth K. Tanabe  Journal of Hepatology  Volume 56, Issue 3, Pages 729-730 (March 2012) DOI: 10.1016/j.jhep.2011.08.015 Copyright © 2011 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Progression of chronic hepatitis C. After the establishment of chronic infection of hepatitis C virus, a subset of patients progresses into the next disease state assumedly through the interaction of host genetic, viral, and/or environmental risk factors. Risk allele A at rs2596542 is not associated with susceptibility to hepatitis C infection but is associated with occurrence of HCC. It remains to be determined exactly how risk allele A increases the risk of HCC development; for example by inducing chronic active hepatitis, cirrhosis progression, or tumor formation. Journal of Hepatology 2012 56, 729-730DOI: (10.1016/j.jhep.2011.08.015) Copyright © 2011 European Association for the Study of the Liver Terms and Conditions